R500.00
Tesamorelin is a synthetic peptide that stimulates the body’s natural release of
growth hormone (GH) by activating growth hormone–releasing hormone (GHRH) receptors in the pituitary gland.
It is commonly studied for its role in supporting fat metabolism, body composition improvement, and IGF-1 signalling, particularly in relation to reduction of visceral (abdominal) fat.
Tesamorelin works by signalling the brain to increase natural growth hormone production rather than supplying synthetic growth hormone directly.
Because tesamorelin works through the body’s own hormone signalling system, it is often preferred over direct growth hormone replacement in metabolic-support protocols.
Tesamorelin is a well-studied peptide that has been evaluated extensively for its effects on visceral fat reduction and metabolic regulation.
Clinical studies have demonstrated measurable reductions in abdominal visceral fat along with increases in IGF-1 levels when used consistently over time.
Tesamorelin works differently from traditional growth hormone therapy by encouraging the body’s own natural hormone production instead of replacing it directly.
A commonly used clinical protocol for tesamorelin is:
It is typically administered at the same time each day to support consistent growth hormone signalling activity.
Dosage may vary depending on individual goals and guidance from a qualified healthcare professional.
Tesamorelin is supplied as a freeze-dried powder and must be mixed before use.
Tesamorelin is a specialised peptide compound.
